Team:BrownTwo/Implementation/yeast
From 2008.igem.org
(→Understanding our chassis) |
|||
Line 1: | Line 1: | ||
{{limitertemp}} | {{limitertemp}} | ||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | |||
- | == | + | |
+ | == Saccharomyces cerevisiae == | ||
Yeast is a well-characterized yet relatively simple eukaryotic model. This is important given that we wish our device to have eventual application to mammalian models in which abnormal gene regulation can lead to disease conditions. | Yeast is a well-characterized yet relatively simple eukaryotic model. This is important given that we wish our device to have eventual application to mammalian models in which abnormal gene regulation can lead to disease conditions. |
Revision as of 01:33, 30 October 2008
Saccharomyces cerevisiaeYeast is a well-characterized yet relatively simple eukaryotic model. This is important given that we wish our device to have eventual application to mammalian models in which abnormal gene regulation can lead to disease conditions.
Another key disctinction between prokaryotic and eukaryotic systems is that, due to the extensive compartmentalization seen in eukaryotic cells, transcription and translation occur within different locations of the cell. Transcription of precursor mRNA molecules takes places inside the nucleus. Additional modifications are made to the precursor mRNA before it leaves the nucleus, one of the most noteworthy being the splicing of introns or non-coding regions from the mRNA. It is the absence of a comparable system of modifications in prokaryotes that provides the first barrier to cloning many mammalian proteins in E. coli. By nature of their physical separation, the two processes are also distinguished by a temporal independence of one another,
|